Momenta Pharmaceuticals Inc (NASDAQ:MNTA) saw a big move last session, as the company’s shares fell by nearly 17% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for MNTA as the stock is now down over 28% since March 19. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares after opening at $10.46 moved to $11.04 on last trade day and at the end of the day closed at $10.40. Company price to sales ratio in past twelve months was calculated as 15.37 and price to cash ratio as 2.22. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) showed a negative weekly performance of -7.56%.
Spectrum Pharmaceuticals (NASDAQ:SPPI) was downgraded by investment analysts at TheStreet from a “hold” rating to a “sell” rating in a note issued to investors on Monday, Analyst Ratings Net reports. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares fell -5.17% in last trading session and ended the day on $6.79. SPPI return on equity ratio is recorded as -23.50% and its return on assets is -14.30%. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) yearly performance is -6.60%.
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) announced that results of two new preclinical studies evaluating novel combinations of TH-302. Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) shares moved down -6.47% in last trading session and was closed at $4.05 while trading in range of $3.92 – $4.47 – Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) year to date (YTD) performance is -13.28%.
Curis, Inc. (NASDAQ:CRIS), announced that it reported data from in vitrostudies and a translational biomarker analysis for CUDC-907, a dual histone deacytelase (HDAC) and phosphoinositide 3-kinase (PI3K) inhibitor, as well as results from in vitro andin vivo studies for CUDC-427, an antagonist of inhibitor of apoptosis (IAP) proteins, at the American Association for Cancer Research (AACR) 2014 Annual Meeting. Curis, Inc. (NASDAQ:CRIS) weekly performance is -10.57%. On last trading day company shares ended up $2.37. Curis, Inc. (NASDAQ:CRIS) distance from 50-day simple moving average (SMA50) is -20.08%. Analysts mean target price for the company is $5.72.
Leave a Reply